The Medtech Marathon: Hitting Milestones in a Delayed Revenue World with Dr. Ben Holmes

Join Dr. Ben Holmes, CEO and Co-Founder of Nanochon, for a strategic look at the high-stakes world of medical device innovation. With a Ph.D. in biomedical engineering and a background in aerospace engineering, Ben has spent nearly a decade navigating the "long runway" of medtech. In this episode, we discuss how Nanochon is moving toward its first-in-human clinical trials with the Chondrograft™—a 3D-printed synthetic implant—and how founders can create tangible enterprise value years before their first dollar of commercial revenue.🎯 Insights You’ll Learn:The Medtech Milestone Map: How to define and hit value-inflection points during a long R&D cycle.Fundraising for the Long Haul: Strategies for securing $12M+ through a blend of NSF grants and venture capital.3D Printing the Future: How additive manufacturing is solving the "cartilage gap" for patients too young for knee replacement.De-Risking for Investors: Converting scientific breakthroughs into "investable" regulatory and clinical progress.The Founder-Scientist Balance: Transitioning from a Ph.D. researcher to a CEO managing complex cap tables and clinical sites.Collaborative Innovation: Building a community in the healthcare 3D printing space to accelerate global adoption.First-in-Human Readiness: What it actually takes to move a 3D-printed synthetic biomaterial into the operating room.🌍 Why This Matters:Biotech and medtech founders face a unique challenge: they must sustain operations and investor interest for years without traditional sales. Dr. Ben Holmes has mastered the art of "value engineering," showing that progress in the lab and the regulatory office is just as measurable as quarterly revenue. By focusing on Chondrograft™—a solution for the millions of patients stuck between minor physical therapy and total joint replacement—Nanochon is proving that 3D-printed biomaterials are the key to the next generation of orthopedic care.👤 Expert Background:CEO & Co-Founder of Nanochon, a clinical-stage medtech company.Ph.D. in Biomedical Engineering from The George Washington University.Expert in 3D Printing and Biomaterials with a B.S. in Mechanical and Aerospace Engineering.Successful Fundraiser with nearly $12M secured via non-dilutive grants and VC.Published Researcher and Patent Holder in the field of orthopedic tissue repair.🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders navigating the realities of building in the AI era.💡 Perfect For:Medtech founders, biotech investors, biomedical engineers, orthopedic surgeons, and hardware entrepreneurs navigating long-cycle regulatory pathways.🚀 Timely Topic:In 2026, the intersection of AI-driven design and 3D printing is shortening the distance between a lab concept and a clinical reality. Dr. Ben Holmes provides the blueprint for founders who want to survive the marathon and cross the clinical finish line.Subscribe for more global founder conversations from GSD Venture Studios:https://gsdvs.com#Medtech #Nanochon #BiomedicalEngineering #3DPrinting #HealthcareInnovation #Orthopedics #BenHolmes #GaryFowler #GSDVentureStudios